Drug details

Veklury (remdesivir for injection)

type of Antivirals, Other, SARS-CoV-2 Antivirals

Veklury (remdesivir) is a SARS-CoV-2 nucleotide analog RNA polymerase inhibitor indicated for adults and pediatric patients (12 years of age and older and weighing at least 40 kg) for the treatment of coronavirus disease 2019 (COVID-19) requiring hospitalization.

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• nausea,
• itching,
• fever,
• chills,
• severe headache,
• pounding in your neck or ears,
• wheezing,
• shivering,
• lightheadedness
• sweating, and
• fast, slow, or pounding heartbeats,

The following drugs are related to Veklury, either as a replacement or used together:

• Bebtelovimab (bebtelovimab)
• Novavax (covid-19 vaccine for intramuscular injection)
• Spikevax (covid-19 vaccine, mrna suspension for injection)
• Evusheld (tixagevimab injection; cilgavimab injection, copackaged for intramuscular use)
• Gohibic (vilobelimab injection)
• Lagevrio (molnupiravir)
• Paxlovid (nirmatrelvir tablets and ritonavir tablets)
• Xevudy (sotrovimab injection)